State Street’s Cocrystal Pharma COCP Stock Holding History

State Street’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.6K	Hold	20,543	–	–	﹤0.01%	4130
2026 Q1	$20.7K	Hold	20,543	–	–	﹤0.01%	4211
2025 Q4	$20.1K	Hold	20,543	–	–	﹤0.01%	4244
2025 Q3	$25.7K	Hold	20,543	–	–	﹤0.01%	4228
2025 Q2	$30.6K	Hold	20,543	–	–	﹤0.01%	4161
2025 Q1	$29.2K	Hold	20,543	–	–	﹤0.01%	4162
2024 Q4	$41.5K	Hold	20,543	–	–	﹤0.01%	4135
2024 Q3	$36.2K	Hold	20,543	–	–	﹤0.01%	4153
2024 Q2	$47.9K	Sell	20,543 -3,900	-16%	-$7.6K	﹤0.01%	4148
2024 Q1	$35K	Hold	24,443	–	–	﹤0.01%	4217
2023 Q4	$41.6K	Hold	24,443	–	–	﹤0.01%	4226
2023 Q3	$45.7K	Hold	24,443	–	–	﹤0.01%	4310
2023 Q2	$58.4K	Hold	24,443	–	–	﹤0.01%	4380
2023 Q1	$48.4K	Hold	24,443	–	–	﹤0.01%	4510
2022 Q4	$47.2K	Buy	24,443 +2	+0%	+$5	﹤0.01%	4570
2022 Q3	$85K	Hold	24,441	–	–	﹤0.01%	4517
2022 Q2	$120K	Hold	24,441	–	–	﹤0.01%	4437
2022 Q1	$161K	Buy	24,441 +1,572	+7%	+$10.5K	﹤0.01%	4459
2021 Q4	$178K	Hold	22,869	–	–	﹤0.01%	4395
2021 Q3	$288K	Hold	22,869	–	–	﹤0.01%	4219
2021 Q2	$343K	Buy	+22,869	New	+$348K	﹤0.01%	4001

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street's COCP Position: Q2 2026 in Review

State Street held its Cocrystal Pharma (COCP) position steady in Q2 2026 at 20,543 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4130.

State Street first reported a position in COCP in Q2 2021 and has held it in 21 quarters since. The position peaked at $343K in Q2 2021. 22 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

State Street held 20,543 shares of Cocrystal Pharma worth $21.6K as of Q2 2026.
State Street left its Cocrystal Pharma share count unchanged in Q2 2026.
Cocrystal Pharma made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4130 holding.
State Street first reported a position in Cocrystal Pharma in Q2 2021 and has held it in 21 quarters since.
State Street's Cocrystal Pharma position peaked at $343K in Q2 2021.
22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.